Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://journals.lww.com/appliedimmunohist/abstract/2004/03000/her_2_neu__c_erbb_2__evaluation_in_primary_breast.3.aspx, but it redirected us to https://journals.lww.com/appliedimmunohist/abstract/2004/03000/her_2_neu__c_erbb_2__evaluation_in_primary_breast.3.aspx. The analysis below is for the second page.

Title[redir]:
Applied Immunohistochemistry & Molecular Morphology
Description:
sections. Twelve of these 48 tumors had a difference of at least 2 arbitrary units in the in situ compared with the invasive part of the tumor with regard to the HER-2/neu status analyzed by HercepTest (immunohistochemistry). Eight of these 12 tumors were reanalyzed with fluorescent in situ hybridization and immunohistochemistry with and without a new Automated Cellular Imaging System. In this limited material, immunohistochemistry in combination with the Automated Cellular Imaging System seemed to have a better correlation with fluorescent in situ hybridization than immunostaining analyzed manually. In conclusion, HER-2/neu expression is not seldom heterogeneous in invasive compared with in situ components within a tumor. This finding should be considered in the choice of evaluation method. To avoid heterogeneity as a confounding factor in HER-2/neu analyses, detection methods such as immunohistochemistry and fluorescent in situ hybridization, which can provide evaluation in a preserved tissue architecture, should be used. Perhaps the intratumor HER-2/neu heterogeneity can explain some of the unexpected failures of trastuzumab therapy....

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Non-Profit & Charity

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is built with MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

journal, situ, herneu, immunohistochemistry, invasive, heterogeneity, issue, fluorescent, hybridization, tumors, access, subscribe, alerts, articles, authors, abstract, evaluation, intratumor, components, phd, analyzed, log, register, issues, primary, breast, buy, tissue, compared, tumor, automated, cellular, imaging, system, text, subscribers, request, browse, content, submit, service, privacy, policy, logo, advanced, search, info, previous, research, cerbb,

Topics {✒️}

primary breast carcinoma journal authors submit full text access analyzed tissue sections immunostaining analyzed manually preserved tissue architecture artificial intelligence training 2/neu status analyzed service request 800-638-3030 etoc alerts register subscribe individual subscribers log buy abstract journal tables issue website subscribe invasive components journal invasive component invasive part invasive compared center submit situ components c-erbb-2 situ hybridization special focus jenny md barbro md jonas md goran md 2 arbitrary units situ compared limited material 2/neu expression seldom heterogeneous confounding factor 2/neu analyses detection methods unexpected failures trastuzumab therapy email inbox rights reserved data mining 2/neu heterogeneity avoid heterogeneity evaluation method provide evaluation intratumor heterogeneity phd authors

Questions {❓}

  • Not a Subscriber?

External Links {🔗}(57)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

5.31s.